NCT03993158 Newborns From Patients Treated With ART (Assisted Reproductive Technology)
| NCT ID | NCT03993158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Zhengzhou University |
| Condition | Health Related |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2010-01-01 |
| Primary Completion | 2050-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2010-01-01 with a primary completion date of 2050-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Prospective Cohort Study for Newborns from patients treated with ART was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.
Eligibility Criteria
Inclusion Criteria: * All newborns from patients treated with ART in our center. Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03993158 clinical trial?
This trial is open to participants of all sexes, aged 0 Weeks or older, up to 40 Years, studying Health Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03993158 currently recruiting?
Yes, NCT03993158 is actively recruiting participants. Contact the research team at rmczzu@126.com for enrollment information.
Where is the NCT03993158 trial being conducted?
This trial is being conducted at Zhengzhou, China.
Who is sponsoring the NCT03993158 clinical trial?
NCT03993158 is sponsored by The First Affiliated Hospital of Zhengzhou University. The trial plans to enroll 10,000 participants.